全國服務咨詢熱線:
15921799099
<pre id="4azcc"></pre>
15921799099
Matriks Biotek專門生產針對抗體藥的ELISA試劑盒，用于檢測抗體藥的體內含量或因用于產生的針對相應抗體藥的抗體的體內含量。Matriks Biotek®, SHIKARI®和KLONART®為Matriks生物技術公司注冊的產品商標。其產品達到ISO 13485 & CE IVD標準。
MatriksBiotek2020年價格表
| 貨號 | 品名 | cas | 價格j |
| INF-FD-REMI | Shikari® Infliximab | Shikari® (Q-INFLIXI) | 14500 |
| INF-QLS-REMI | Shikari® Qualitative Antibodies to Infliximab | Shikari® (Q-ATI) | 14500 |
| INF-QNS-REMI | Shikari® Quantitative Antibodies to Infliximab | Shikari® (Q-ATI) | 15000 |
| INF-QNFT-REMI | Shikari® Semi-Quantitative Antibodies (Free/Total) to Infliximab | Shikari® (Q-ATIDUO) | 15000 |
| INF-FD-REMS | Shikari® Infliximab | Shikari® (Q-REMS) | 14500 |
| INF-QLS-REMS | Shikari® Qualitative Antibodies to Infliximab | Shikari® (S-AIR) | 14500 |
| INF-QNS-REMS | Shikari® Quantitative Antibodies to Infliximab | Shikari® (S-AIR) | 15000 |
| INF-QNT-REMS | Shikari® Semi-Quantitative Antibodies (Free/Total) to Infliximab | Shikari® (S-AIR) | 15000 |
| ADA-FD-HUM | Shikari® Adalimumab | Shikari® (Q-ADA) | 14500 |
| ADA-QLS-HUM | Shikari® Qualitative Antibodies to Adalimumab | Shikari® (S-ATA) | 14500 |
| ADA-QNS-HUM | Shikari® Quantitative Antibodies to Adalimumab | Shikari® (S-ATA) | 15000 |
| ADA-QNFT-HUM | Shikari® Semi-Quantitative Antibodies (Free/Total) to Adalimumab | Shikari® (S-ATA) | 15000 |
| ETA-FD-ENB | Shikari® Etanercept | Shikari® (Q-ETA) | 15000 |
| ETA-QLS-ENB | Shikari® Qualitative Antibodies to Etanercept | Shikari® (S-ATE) | 15000 |
| GOL-FD-SIM | Shikari® Golimumab | Shikari® (Q-GOL) | 14500 |
| GOL-QLS-SIM | Shikari® Qualitative Antibodies to Golimumab | Shikari® (S-ATG) | 14500 |
| CER-FD-CIM | Shikari® Certolizumab | Shikari® (Q-CERT) | 15000 |
| VED-FD-ENT | Shikari® Vedolizumab | Shikari® (Q-VEDO) | 16000 |
| VED-QLS-ENT | Shikari® Qualitative Antibodies to Vedolizumab | Shikari® (S-ATV) | 16000 |
| UST-FD-STE | Shikari® Ustekinumab | Shikari® (Q-UST) | 16000 |
| UST-QLS-STE | Shikari® Qualitative Antibodies to Ustekinumab | Shikari® (S-ATU) | 16000 |
| RAM-FD-CYR | Shikari® Ramucirumab | Shikari® (Q-RAM) | 16000 |
| RAM-QLS-CYR | Shikari® Qualitative Antibodies to Ramucirumab | Shikari® (S-ATRAM) | 15000 |
| BEV-FD-AA | Shikari® Bevacizumab | Shikari® (Q-BEVA) | 14500 |
| BEV-QLS-AA | Shikari® Qualitative Antibodies to Bevacizumab | Shikari® (S-ATB) | 14500 |
| BEV-QNS-AA | Shikari® Quantitative Antibodies to Bevacizumab | Shikari® (S-ATB) | 15000 |
| RIT-FD-RM | Shikari® Rituximab | Shikari® (Q-RITUX) | 14500 |
| RIT-QLS-RM | Shikari® Qualitative Antibodies to Rituximab | Shikari® (S-ATR) | 14500 |
| RIT-QNS-RM | Shikari® Quantitative Antibodies to Rituximab | Shikari® (S-ATR) | 15000 |
| TRA-FD-HH | Shikari® Trastuzumab | Shikari® (Q-TRAS) | 14500 |
| TRA-QLS-HH | Shikari® Qualitative Antibodies to Trastuzumab | Shikari® (S-ATT) | 14500 |
| TRA-QNS-HH | Shikari® Quantitative Antibodies to Trastuzumab | Shikari® (S-ATT) | 15000 |
| CET-FD-ERB | Shikari® Cetuximab | Shikari® (Q-CET) | 14500 |
| CET-QLS-ERB | Shikari® Qualitative Antibodies to Cetuximab | Shikari® (S-ATC) | 14500 |
| CET-QNS-ERB | Shikari® Quantitative Antibodies to Cetuximab | Shikari® (S-ATC) | 15000 |
| DEN-FD-PRO | Shikari® Denosumab | Shikari® (Q-DEN) | 16000 |
| DEN-QLS-PRO | Shikari® Qualitative Antibodies to Denosumab | Shikari® (S-ATD) | 16000 |
| FIL-QLS-FRA | Shikari® Qualitative Antibodies to Filgrastim | Shikari® (S-AFA) | 17000 |
| FIL-QNS-FRA | Shikari® Quantitative Antibodies to Filgrastim | Shikari® (Q-AFA) | 19000 |
| OMA-FD-XOL | Shikari® Omalizumab | Shikari® (Q-OMA) | 14500 |
| OMA-QLS-XOL | Shikari® Qualitative Antibodies to Omalizumab | Shikari® (S-ATO) | 14500 |
| RAN-FD-LUC | Shikari® Ranibizumab | Shikari® (Q-RAN) | 16000 |
| AVE-FD-BAV | Shikari® Avelumab | Shikari® (Q-AVE) | 16000 |
| AVE-QLS-BAV | Shikari® Qualitative Antibodies to Avelumab | Shikari® (S-ATAV) | 15000 |
| NIV-FD-OPD | Shikari® Nivolumab | Shikari® (Q-NIVO) | 16000 |
| NIV-QLS-OPD | Shikari® Qualitative Antibodies to Nivolumab | Shikari® (S-ATN) | 15000 |
| PEM-FD-KEY | Shikari® Pembrolizumab | Shikari® (Q-PEM) | 16000 |
| PEM-QLS-KEY | Shikari® Qualitative Antibodies to Pembrolizumab | Shikari® (S-ATP) | 15000 |
| IPI-FD-YER | Shikari® Ipilimumab | Shikari® (Q-IPI) | 16000 |
| IPI-QLS-YER | Shikari® Qualitative Antibodies to Ipilimumab | Shikari® (S-ATI) | 15000 |
電話
微信
當前位置：
地址：上海浦東川沙鎮川沙路6619號上海起發實驗試劑有限公司
郵箱：xs1@78bio.com
傳真：021-50724961